Interagency Task Force on Antimicrobial Resistance (ITFAR) Public Meeting, 41695-41696 [2014-16790]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 137 / Thursday, July 17, 2014 / Notices
into a web system administered by CDC.
Information is collected from these
records about the characteristics of the
victims and suspects, the circumstances
of the deaths, and the weapons
involved. States use standardized data
elements and software designed by CDC.
Ultimately, this information will guide
states in designing, targeting, and
evaluating programs that reduce
multiple forms of violence. Neither
victim’s families nor suspects are
contacted to collect this information; it
all comes from existing records and is
collected by state health department
staff or their subcontractors. The
number of hours per death required for
the public agencies working with
NVDRS states to retrieve and then refile
their records is estimated to be 0.5 hours
per death.
The president has submitted plans to
fund the expansion of the state-based
surveillance system to collect
information in all 50 U.S. states, the
District of Columbia, and U.S.
territories. This revision will allow 32
new state health departments, the health
department of the District of Columbia,
and 7 territorial governments to be
added to the currently funded 18 state
health departments, resulting in a total
of 58 public health agencies, which
include the 50 U.S. states, the District of
Columbia, and territories to be included
in the state-based surveillance system.
Violent deaths include all homicides,
suicides, legal interventions, deaths
from undetermined causes, and
41695
unintentional firearm deaths. The
average state will experience
approximately 1,000 such deaths each
year.
In the past, abstractors’ time was
included as burden as they were not
compensated to abstract data from death
certificates. Moving forward, we will no
longer include state abstractors’ time
spent abstracting data in our estimates
of public burden for NVDRS because
state abstractors are funded by CDC to
do this work. This significantly reduces
the estimated public burden associated
with NVDRS.
There are no costs to respondents
other than their time. The total
estimated annual burden hours are
29,000.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Responses
per
respondent
Average
burden per
response
(in hrs.)
Public Agencies ..............................................
NVDRS Web System .....................................
58
1,000
30/60
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–16841 Filed 7–16–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Interagency Task Force on
Antimicrobial Resistance (ITFAR)
Public Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of public meeting.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), Food and
Drug Administration (FDA), and
National Institutes of Health (NIH), all
located within the Department of Health
and Human Services, in collaboration
with partner agencies, announce a
public meeting concerning
antimicrobial resistance. CDC, FDA, and
NIH serve as Co-Chairs to the
Interagency Task Force on
Antimicrobial Resistance (ITFAR). The
purpose of the meeting is to
communicate the strategic direction of
ITFAR in the fight against antimicrobial
pmangrum on DSK3VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:01 Jul 16, 2014
Jkt 232001
resistance, centering on current work
and future direction in this area.
DATES: The public meeting will be held
at the Ronald Reagan Building and
International Trade Center in
Washington, DC, on Thursday,
September 4, 2014, from 1:00 p.m. to
5:00 p.m.
Deadline for Registration for all
Attendees: All attendees must register
by 12:00 p.m. EDT, Monday, August 18,
2014.
Deadline for Requests for Special
Accommodation: Special
accommodation requests must be
submitted to ITFAR@cdc.gov by 12:00
p.m. EDT, Monday, August 18, 2014.
ADDRESSES: The public meeting will be
held at the Ronald Reagan Building and
International Trade Center, Horizon
Ballroom, 1300 Pennsylvania Avenue
NW., Washington, DC 20004;
Telephone: 202–312–1300.
Participants should be aware that the
meeting location is a Federal
government building; therefore, Federal
security measures are applicable. Please
see Building and Security Guidelines for
information on security requirements.
Additional visitor information is
available at https://www.itcdc.com.
FOR FURTHER INFORMATION CONTACT:
Stephanie Gumbis, Office of
Antimicrobial Resistance, National
Center for Emerging and Zoonotic
Infectious Diseases, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., Mailstop A–28, Atlanta, GA
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
30329; Telephone 404–639–4000; Email
ITFAR@cdc.gov.
SUPPLEMENTARY INFORMATION:
1. Background
The Interagency Task Force on
Antimicrobial Resistance (ITFAR) was
created in 1999 in recognition of the
increasing importance of antimicrobial
resistance (AR) as a public health threat.
The ITFAR coordinates the activities of
federal agencies in addressing
antimicrobial resistance and is cochaired by HHS/CDC, HHS/FDA, and
HHS/NIH. Other HHS Task Force
members include the Agency for
Healthcare Research and Quality
(AHRQ), the Centers for Medicare and
Medicaid Services (CMS), the Health
Resources and Services Administration
(HRSA), the HHS Office of the Assistant
Secretary for Preparedness and
Response (HHS/ASPR) and the HHS
Office of the Assistant Secretary of
Health (HHS/OASH). Non-HHS Task
Force members include the Department
of Agriculture (USDA), the Department
of Defense (DoD), the Department of
Veterans Affairs (VA), and the
Environmental Protection Agency
(EPA).
In 2001, the ITFAR developed an
initial action plan to combat AR. This
plan, titled ‘‘A Public Health Action
Plan to Combat Antimicrobial
Resistance,’’ outlined specific goals,
actions, and implementation steps
important for addressing the problem of
E:\FR\FM\17JYN1.SGM
17JYN1
41696
Federal Register / Vol. 79, No. 137 / Thursday, July 17, 2014 / Notices
antimicrobial resistance. Action items
were organized into focus areas:
Surveillance, Prevention and Control,
Research, and Product Development.
The 2001 Action Plan was revised in
2011 and 2012 to address the evolving
threat of antimicrobial resistance. A
revised draft of the Action Plan is under
development and will be available for
public comment later this year.
pmangrum on DSK3VPTVN1PROD with NOTICES
2. Public Comment and Meeting
The public meeting process provides
an opportunity for the public to
comment on the activities of the ITFAR
to date. The agenda will consist of
welcome and introductory comments
followed by sessions centering on
specific topics in each of the three focus
areas of the Action Plan: Surveillance,
Prevention and Control of Antimicrobial
Resistance; Research; and Regulatory
Pathways to Promote Product
Development. Each session will include
presentations by the ITFAR members on
the strategic direction of government
agencies for that Focus Area followed by
brief presentations from invited partner
organizations. The session will end with
a moderated question and answer
session with the audience. The meeting
will then be open for comments from
the general public. The agenda is subject
to change without notice.
Comments and suggestions from the
public on the ITFAR or any of the focus
areas of the Action Plan will be
reviewed and carefully considered by
the ITFAR. The public should be aware
that this meeting agenda does not
include development of consensus
positions, guidelines, interrogatories, or
discussions or endorsement of specific
commercial products.
3. Registration To Attend or Participate
in the Public Meeting
Participants are asked to preregister to
ensure sufficient space. Seating capacity
is limited to 200 persons. To register,
please send an electronic mail message
to ITFAR@cdc.gov by 12:00 p.m. EDT,
Monday, August 18, 2014. Your email
should include your name, and email
address. Because of time restrictions,
the moderated question and answer
session with the audience and the time
for comments from the general public
will be limited by the time allotted on
the agenda. However, additional
comments may be submitted in writing
following the public meeting;
instructions for submission are listed in
ADDRESSES.
4. Building and Security Guidelines
The meeting is being held in a Federal
government building; therefore, Federal
security measures are applicable. In
VerDate Mar<15>2010
15:01 Jul 16, 2014
Jkt 232001
planning your arrival, please take into
account the need to clear security. All
visitors entering the Ronald Reagan
Building must procede as directed
through security checkpoints and
present government-issued photo
identification (e.g., a valid Federal
identification badge, state driver’s
license, state non-driver’s license, or
passport). All visitors entering the
building must pass through a metal
detector. All items brought to Ronald
Reagan Building may be subject to
inspection.
Dated: July 14, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2014–16790 Filed 7–16–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0987]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Quantitative
Testing as Used by the Food and Drug
Administration Center for Tobacco
Products
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
quantitative testing as used by the Food
and Drug Administration Center for
Tobacco Products.
DATES: Submit either electronic or
written comments on the collection of
information by September 15, 2014.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. All
comments should be identified with the
SUMMARY:
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
docket number found in brackets in the
heading of this document.
FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate and other forms of
information technology.
SUPPLEMENTARY INFORMATION:
Quantitative Testing as Used by the
Food and Drug Administration Center
for Tobacco Products (OMB Control
Number 0910—NEW)
In order to conduct educational and
public information programs relating to
tobacco use as authorized by section
1003(d)(2)(D) of the Federal Food Drug
and Cosmetic Act (21 U.S.C.
393(d)(2)(D)), FDA’s Center for Tobacco
Products will create and use a variety of
media to inform and educate the public,
tobacco retailers, and health
professionals about the risks of tobacco
use, how to quit using tobacco products,
and FDA’s role in regulating tobacco.
E:\FR\FM\17JYN1.SGM
17JYN1
]]>Agencies
[Federal Register Volume 79, Number 137 (Thursday, July 17, 2014)]
[Notices]
[Pages 41695-41696]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-16790]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Interagency Task Force on Antimicrobial Resistance (ITFAR) Public
Meeting
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), Food and
Drug Administration (FDA), and National Institutes of Health (NIH), all
located within the Department of Health and Human Services, in
collaboration with partner agencies, announce a public meeting
concerning antimicrobial resistance. CDC, FDA, and NIH serve as Co-
Chairs to the Interagency Task Force on Antimicrobial Resistance
(ITFAR). The purpose of the meeting is to communicate the strategic
direction of ITFAR in the fight against antimicrobial resistance,
centering on current work and future direction in this area.
DATES: The public meeting will be held at the Ronald Reagan Building
and International Trade Center in Washington, DC, on Thursday,
September 4, 2014, from 1:00 p.m. to 5:00 p.m.
Deadline for Registration for all Attendees: All attendees must
register by 12:00 p.m. EDT, Monday, August 18, 2014.
Deadline for Requests for Special Accommodation: Special
accommodation requests must be submitted to ITFAR@cdc.gov by 12:00 p.m.
EDT, Monday, August 18, 2014.
ADDRESSES: The public meeting will be held at the Ronald Reagan
Building and International Trade Center, Horizon Ballroom, 1300
Pennsylvania Avenue NW., Washington, DC 20004; Telephone: 202-312-1300.
Participants should be aware that the meeting location is a Federal
government building; therefore, Federal security measures are
applicable. Please see Building and Security Guidelines for information
on security requirements. Additional visitor information is available
at https://www.itcdc.com.
FOR FURTHER INFORMATION CONTACT: Stephanie Gumbis, Office of
Antimicrobial Resistance, National Center for Emerging and Zoonotic
Infectious Diseases, Centers for Disease Control and Prevention, 1600
Clifton Road NE., Mailstop A-28, Atlanta, GA 30329; Telephone 404-639-
4000; Email ITFAR@cdc.gov.
SUPPLEMENTARY INFORMATION:
1. Background
The Interagency Task Force on Antimicrobial Resistance (ITFAR) was
created in 1999 in recognition of the increasing importance of
antimicrobial resistance (AR) as a public health threat. The ITFAR
coordinates the activities of federal agencies in addressing
antimicrobial resistance and is co-chaired by HHS/CDC, HHS/FDA, and
HHS/NIH. Other HHS Task Force members include the Agency for Healthcare
Research and Quality (AHRQ), the Centers for Medicare and Medicaid
Services (CMS), the Health Resources and Services Administration
(HRSA), the HHS Office of the Assistant Secretary for Preparedness and
Response (HHS/ASPR) and the HHS Office of the Assistant Secretary of
Health (HHS/OASH). Non-HHS Task Force members include the Department of
Agriculture (USDA), the Department of Defense (DoD), the Department of
Veterans Affairs (VA), and the Environmental Protection Agency (EPA).
In 2001, the ITFAR developed an initial action plan to combat AR.
This plan, titled ``A Public Health Action Plan to Combat Antimicrobial
Resistance,'' outlined specific goals, actions, and implementation
steps important for addressing the problem of
[[Page 41696]]
antimicrobial resistance. Action items were organized into focus areas:
Surveillance, Prevention and Control, Research, and Product
Development. The 2001 Action Plan was revised in 2011 and 2012 to
address the evolving threat of antimicrobial resistance. A revised
draft of the Action Plan is under development and will be available for
public comment later this year.
2. Public Comment and Meeting
The public meeting process provides an opportunity for the public
to comment on the activities of the ITFAR to date. The agenda will
consist of welcome and introductory comments followed by sessions
centering on specific topics in each of the three focus areas of the
Action Plan: Surveillance, Prevention and Control of Antimicrobial
Resistance; Research; and Regulatory Pathways to Promote Product
Development. Each session will include presentations by the ITFAR
members on the strategic direction of government agencies for that
Focus Area followed by brief presentations from invited partner
organizations. The session will end with a moderated question and
answer session with the audience. The meeting will then be open for
comments from the general public. The agenda is subject to change
without notice.
Comments and suggestions from the public on the ITFAR or any of the
focus areas of the Action Plan will be reviewed and carefully
considered by the ITFAR. The public should be aware that this meeting
agenda does not include development of consensus positions, guidelines,
interrogatories, or discussions or endorsement of specific commercial
products.
3. Registration To Attend or Participate in the Public Meeting
Participants are asked to preregister to ensure sufficient space.
Seating capacity is limited to 200 persons. To register, please send an
electronic mail message to ITFAR@cdc.gov by 12:00 p.m. EDT, Monday,
August 18, 2014. Your email should include your name, and email
address. Because of time restrictions, the moderated question and
answer session with the audience and the time for comments from the
general public will be limited by the time allotted on the agenda.
However, additional comments may be submitted in writing following the
public meeting; instructions for submission are listed in ADDRESSES.
4. Building and Security Guidelines
The meeting is being held in a Federal government building;
therefore, Federal security measures are applicable. In planning your
arrival, please take into account the need to clear security. All
visitors entering the Ronald Reagan Building must procede as directed
through security checkpoints and present government-issued photo
identification (e.g., a valid Federal identification badge, state
driver's license, state non-driver's license, or passport). All
visitors entering the building must pass through a metal detector. All
items brought to Ronald Reagan Building may be subject to inspection.
Dated: July 14, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science, Centers for Disease
Control and Prevention.
[FR Doc. 2014-16790 Filed 7-16-14; 8:45 am]
BILLING CODE 4163-18-P
